Primary Open-angle Glaucoma
Chat Highlights
April 16, 2003
Norma Devine, Editor
On Wednesday, April 16, 2003,
Dr.
Rick Wilson, a glaucoma specialist at Wills, and the glaucoma
chat group discussed "Primary Open-angle Glaucoma."
Moderator: The topic
tonight is primary open-angle glaucoma (POAG).
Dr. Rick Wilson: Primary
open-angle glaucoma is the garden-variety open- angle glaucoma.
"Primary" means there is no known cause.
P: Is POAG the most
common of all glaucomas?
Dr. Rick Wilson: It is in
America. In China, primary angle-closure glaucoma is the
most common type.
P: Does "open-angle"
mean the angle is normal?
Dr. Rick Wilson: It just
means that the iris is not in apposition or blocking the trabecular
meshwork. That is, the iris is not up against the trabecular meshwork,
the eye's "drain."
P: Are there other
types of POAG?
Dr. Rick Wilson: Not really.
There are many types of secondary, as compared to open- angle,
glaucoma. However, they are not primary.
P: Which differences
can be seen with microscopy?
Dr. Rick Wilson: With primary,
open-angle glaucoma, the changes seen are the result of aging,
with loss of cells lining the beams of the meshwork, and a build-up
of debris and thickening of the beams.
P: Is open-angle glaucoma
the most treatable form?
Dr. Rick Wilson: No. If
caught early, angle-closure glaucoma often may be reversed.
P: What percentage
of glaucoma patients in the United States have POAG?
Dr. Rick Wilson: My recollection
is about 80% to 85%. About 5% to 10% have angle-closure
glaucoma, and the rest have a secondary glaucoma.
P: Does POAG generally
go undetected more than other types of glaucoma?
Dr. Rick Wilson: Yes, because
it has the fewest symptoms.
P: Is POAG the main
type of glaucoma that leads to blindness?
Dr. Rick Wilson: Actually,
no. Primary angle-closure glaucoma may be less prevalent
on a worldwide basis. But it leads to blindness much more
frequently than open-angle glaucoma, so probably causes more blindness
than open-angle glaucoma.
P: In your opinion,
is POAG very treatable because the frequency of occurrence has
encouraged more research?
Dr. Rick Wilson: No, it is
because POAG is less virulent than some of the other types.
P: In the treatment
of POAG, at what point is surgery inevitable? Can drops
be sufficient? I was under the impression that surgery was
a substitute for the continuous use of drops.
Dr. Rick Wilson: Usually
in America we use drops until they no longer control the IOP (intraocular
pressure). If laser and drops cannot control the IOP, then
surgery would be the next step. In Great Britain, they turn
to surgery much earlier.
P: My understanding
was that POAG is more prevalent in dark-eyed people. My
daughter, who is fair-skinned and blue eyed, was just told by
her eye-care doctor that it is more common with fair-skinned,
light-eyed people. Is that true?
Dr. Rick Wilson: I've never
heard of an iris-color correlation with POAG.
P: Which medication
is considered the front line of defense against POAG?
Dr. Rick Wilson: Usually
one of the prostaglandins or a beta blocker.
P: Can you give an
example of a prostaglandin?
Dr. Rick Wilson: Xalatan,
Travatan, Lumigan, and Rescula are prostaglandins.
P: What percentage
of POAG patients use pilocarpine? Why isn't that more widely
used?
Dr. Rick Wilson: Pilocarpine
has to be used four times a day for optimum control of IOP.
Most patients find that hard to do. It also makes the pupils
small, so everything looks dim, and adapting to darkness is difficult
or impossible.
P: Does treating POAG
differ from treating other forms of glaucoma, and if so, how?
Dr. Rick Wilson: POAG, along
with pseudoexfoliative, pigmentary, and low-tension glaucoma,
is more treatable with laser trabeculoplasty.
P: So, the angle is
normal?
Dr. Rick Wilson: To inspection
at the slit lamp. Electron microscopy can reveal differences
from a normal angle.
P: Is it true that
longer a patient uses glaucoma medication, the less successful
surgery will be? I mean long-term use of the medications.
Dr. Rick Wilson: Yes, that
is true, although the intraoperative use of mitomycin has lessened
the effects of long-term medications on the success of the trabeculectomy.
Moderator: Is normal-tension
glaucoma also primary open-angle glaucoma?
Dr. Rick Wilson: It is one
type of POAG and makes up about 1/6 of POAG patients.
P: Do different types
of glaucoma have different patterns of visual field loss?
Dr. Rick Wilson: Normal-tension
glaucoma is the main type of glaucoma that stands out, and
it often is subtle.
P: When you say that
NTG is the "main type of glaucoma that stands out," are you referring
to the pattern of the visual field defects?
Dr. Rick Wilson: It's the
main type of glaucoma that seems to affect the visual field in
a special way.
P: What clinical differences,
besides IOP, do you actually see between NTG and POAG?
Dr. Rick Wilson: Normal-tension
glaucoma often has deeper visual field defects closer to the center
of vision.
P: I'm sorry my understanding
isn't better, but what do you mean by "deeper visual field defects?"
Dr. Rick Wilson: Denser defects,
in which the patient cannot see a brighter light that he or she
would easily see if the defect were more shallow.
P: Is the cause of
this different visual field pattern in NTG known?
Dr. Rick Wilson: No, although
circulation is suspected.
P: My IOP shot up over
a month to 40 mm Hg. Is that characteristic of open-angle
glaucoma?
Dr. Rick Wilson: If medications
are not being used, open-angle glaucoma is characterized by swings
in IOP over the course of a day that measure on average 11 mm
Hg. Sudden rises in IOP, when everything else is the
same, are unusual.
P: I seem to recall
reading that the slope and/or shape of the cup in normal-tension
glaucoma is a little different from that of POAG, indicating a
different mechanism is at work. Can you comment, please?
Dr. Rick Wilson: For the
same amount of visual field damage in normal-tension glaucoma,
the cup is slightly bigger than it is in POAG. We think
that the causation of normal-tension glaucoma may be more related
to blood circulation than it is in POAG.
End of highlights for April 16, 2003.
On April 23, Dr. Wilson discussed "Neovascular Glaucoma" in
the Chat room. Click here for highlights
of that meeting.
Click here for the most recent
glaucoma chat highlights and links to the chat archives.
Click here for
upcoming glaucoma chat events.
|